Team:Washington/Gram Positive/Test

From 2010.igem.org

(Difference between revisions)
(Enzyme Assay)
(Characterization of best hits)
 
(163 intermediate revisions not shown)
Line 1: Line 1:
 +
__NOTOC__
{{Template:Team:Washington/Templates/Header}}
{{Template:Team:Washington/Templates/Header}}
<html>
<html>
Line 24: Line 25:
</html>
</html>
<!---------------------------------------PAGE CONTENT GOES BELOW THIS---------------------------------------->
<!---------------------------------------PAGE CONTENT GOES BELOW THIS---------------------------------------->
-
=='''Enzyme Assay'''==
 
-
[[Image:Washington_Assay_Scheme_revised2.jpg|thumb|500px|left|The general scheme of our fluorescence-based [https://2010.igem.org/Team:Washington/Protocols/EnzymeAssayCapD enzyme assay]]]
 
-
=='''Reason'''==
 
-
Enzyme assays are commonly used experiments for quantifying enzyme activity by measuring the decrease in substrate or increase in product concentration.
 
-
=='''Measuring Medium'''==
+
=Construction of CapD_CP=
 +
==CapD_CP runs on a gel as one clean band==
-
By continuously measuring the difference in substrate and product fluorescence emission on a plate reader, our assay can quantify the efficiency of CapD_CP mutants.
 
-
=='''Goal'''==
+
[[Image:CapDandCapDCPGell.jpg|480px|left|thumb|'''Figure 1. CapD_CP as expected. Right: CapD has ambiguous bands, making quantifying difficult and assaying protein activity less accurate
-
For this project, two conditions are assayed to determine a mutation's change in hydrolytic activity. The two conditions are: L-Glutamate and no L-Glutamate. For the first condition, because L-Glutamate is the secondary substrate which assists in dissociating the covalent linkage of the primary substrate, PDGA, and CapD_CP, by binding to PDGA, thus releasing and helping in regeneration of the CapD_CP enzyme, we are testing the transpeptidation capability of the enzyme. PDGA is translocated and re-attached to a secondary substrate, L-Glutamate. For the second condition, water is used in place of L-Glutamate as the secondary substrate to release the enzyme from PDGA. Water has a low affinity for our enzyme; therefore, the expected result is a slower rate of regeneration, and thus lower overall enzyme activity. The ultimate goal for the project is to make mutant designs which increase the rate of hydrolysis.
+
''']]
-
=='''Materials'''==
 
-
To assimilate the cleavage process occurring in-vitro, we use a lab-safe PDGA that contains a linked fluorophore and quencher. When the link exists, there is no emission due to light illumination from the plate reader because all light energy is absorbed by the quencher. When the PDGA is cleaved by our enzyme, the embedded linked fluorophore and quencher is disrupted, preventing the quencher from absorbing the light energy and allowing light emission which can be measured by the plater reader.
 
-
=='''Data Analysis'''==
+
Depicted in Figure 1 is a gel comparing purified CapD and CapD_CP. This demonstrates one of the major advantages of CapD_CP,in addition to the fact that it is easy to express, it comes out in one clean band and is easy to quantify.  
-
===CapDCP Activity Validation===
+
-
Before we predict which mutations increase hydrolysis capability, we need to validate that the circularly permuted version of CapD has measurable activity for further assessments. We also hypothesize a threonine residue in the catalytic site of CapD_CP plays an important role in the catalysis reaction and mutating it will eliminate all enzymatic activity. Thus we created two mutants, T2V and T2A, to act as negative controls. The result (figure 1 below) of this assay confirms our hypothesis that CapD_CP has enzymatic activity to the two catalytic knockouts. The relatively flat activity curves of the knockout mutants confirm the hypothesis of the threonine's role in the catalytic site.  
+
-
[[Image:Washington_Confirming_CP_activity_revised3.jpg|thumb|750px|left|Figure 1: Confirming the activity of CapDCP by comparing it to two CapDCP knockouts, T2A and T2V.]]
 
-
===Protein Gel===
+
CapD shows three bands, while the lower two bands are the expected pieces that occur after the enzyme undergoes self cleavage, the upper band is of unclear origin.  Its mass corresponds to what would either be the unprocessed, inactive and monomeric form of the enzymes or the dimeric form that didn't denature.  This ambiguity makes the amount of active CapD enzyme difficult to quantify.
-
[[Image:CapDandCapDCPGell.jpg|thumb|400px|right|Figure 2: Gel showing band intensities of CapDCP and CapD]]
 
-
Before determining the kinectic properties of the two enzyme versions, they were run on an agarose gel (figure 2 on the right) to determine the physical traits. Based on the gel, the two enzymes show different physical properties with CapD producing three bands and CapDCP producing only one. Two of the bands shown for CapD are equal in intensity but different in size. The higher intensity band is the same size as CapDCP's only band.
 
-
<br />
+
<br style="clear: both" />
-
<br />
+
-
<br />
+
-
<br />
+
-
=='''Continuing with CapD_CP'''==
+
==CapD_CP is expressed at EXACTLY the correct molecular weight==
-
[[Image:Washington_CapD_CP_Kinectic_Table_full.jpg|thumb|400px|right|Figure 3 shows the kinetic constants of CapD and CapD_CP]]
+
In Figure 2 (below) we show the mass spec conformation of the molecular weight of CapD_CP. As expected, the N-terminal methionine is cleaved off by the native E. coli methionine aminopeptidase, resulting in a high level of pure active enzyme.
-
Based on the gel's results, CapD_CP was used for future mutant designs. The reason is two-fold. First, CapDCP is easier to quantify due to its single band characteristic. Second, testing with the three unequal and ambiguous bands in CapD would prove problematic since determining which band to measure for active enzyme is nearly impossible.
+
-
After validating the activity of CapDCP, more analysis was done pertaining enzymatic properties. Compiling a Michaelis-Menten profile, the data provides properties of Kcat, Km, Kcat/Km and Ki (see figure 3) for the CapD and CapDCP enzymes. Based on the gel result and the kinetic properties, evidence shows the two versions are very similar, thus all mutants will be done in CapD_CP.
+
-
=='''Analyzing CapD_CP'''==
+
[[Image:CapDCP_MassSpecNoMethionine.png|600px|left|thumb|''' Figure 2.  Expected weight of CapD_CP without Methionine=55285Da, with Methionine=55417Da. Our mass spec detected a peak at 55274.8Da (no Methionine) well within the 0.02% error limit for our mass spec''']]
 +
<br style="clear: both" />
-
[[Image:Washington_CapD_CP_Trans_Hydro_Kinectic_Table_full.jpg|thumb|400px|right|Figure 4 shows the kinetic constants of CapD_CP's transpeptidation and hydrolysis capability]]
+
==The circular permutation didn't result in a loss of activity==
-
[[Image:Washington_CapD_CP_Michaelis_Curve.jpg|thumb|300px|right|]]
 
-
The two abilities of CapD_CP are transpeptidation and hydrolysis. Based on the Kcat and Km (see figure 4)
 
-
values of the two, we conclude that CapDCP is a weak binder and efficient catalyst for the transpeptidation reaction. For hydrolysis, it shows strong binding but slow catalysis. Since the goal is an increase in hydrolysis, mutants enhance the hydrolysis reaction of CapDCP. Since CapD_CP is a strong binder in terms of its hydrolysis capability, strong binding CapDCP mutants must be designed.
 
-
<br />
+
In the table 1 (below), we show the kinetic paramters for CapD and CapD_CP as determined using our [https://2010.igem.org/Team:Washington/Protocols/EnzymeAssayCapD| enzyme assay].
-
<br />
+
Due to the heterogenous mix of active (processed) and inactive (unprocessed) protein, the kcat is difficult to quantify.  The data we obtained suggests that the kinetic parameters of CapD and CapD_CP are within error of each other.  Therefore the circular permutation of CapD did not have a negative effect on catalytic activity, suggesting that auto-processing is not required for catalysis but simply a regulatory feature.
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
=='''Mutant Designs'''==
+
[[Image:Washington_CP_D_Constants.png|thumb|500px|center| '''Table 1. Kinetic properties determined for a Michaelis-Menten profile of CapD and CapD_CP, as described in our  protocols section.''']]
-
By standardizing the activity slope of each design relative to CapD_CP, a scatterplot easily portrays the qualities of each mutant. Several designs show negative catalytic curves similar to the catalytic knockouts. Some immediately show a negative activity curve meaning decrease in transpeptidation, hydrolysis, or both. T20S is a promising mutant hydrolase design.
+
 
 +
 
 +
<br style="clear: both" />
 +
 
 +
==Catalytic Residue knock-outs show that CapD_CP is catalyzing the reaction as expected==
 +
Before we could predict which mutations increase hydrolysis capability, we needed to validate that the circularly permuted version of CapD had measurable activity for further assessments. We also hypothesized a threonine residue in the catalytic site of CapD_CP plays an important role in the catalysis reaction and mutating it will eliminate all enzymatic activity. Thus using [https://2010.igem.org/Team:Washington/Project/Tools/FoldIt FoldIt ]we created two mutants, T2V and T2A, to act as negative controls and ran an [https://2010.igem.org/Team:Washington/Protocols/EnzymeAssayCapD enzyme assay] to confirm our hypothesis. The result shown in figure 3 (below) of this assay confirmed our hypothesis that CapD_CP has enzymatic activity compared to the two catalytic knockouts. The relatively flat activity curves of the knockout mutants confirmed the hypothesis of the threonine's role in the catalytic site.
 +
 
 +
[[Image:Washington_Confirming_CP_activity_revised7.jpg|thumb|750px|left|'''Figure 3: Confirming the activity of CapD_CP by comparing it to two CapD_CP knockouts, T2A and T2V.''']]
 +
<br style="clear: both" />
 +
 
 +
=Removing  CapD_CP Transpeptidase Activity=
 +
<span id = mutant>
 +
==Screening Mutant Libraries==
 +
By standardizing the activity slope of each design relative to CapD_CP, a scatterplot easily portrays the qualities of each mutant. Several designs show negative catalytic curves similar to the catalytic knockouts. Some immediately show a negative activity curve meaning decrease in transpeptidation, hydrolysis, or both. F24H is our most promising mutant hydrolase design.
 +
 
 +
[[Image:Washington_Mutant_design.jpg|thumb|750px|center|'''Figure 4.  Plot of the Transpeptidation vs. Hydrolysis, relative to the starting protein CapD_CP.  The goal is to remove as much transpeptidation activity as possible while maintaining or increasing hydrolysis activity.  This will allow the protein to break down (via the hydrolysis reaction) the protective coat without building it back up (via the transpeptidation reaction)''']]
 +
 
 +
[[Team:Washington/Gram_Positive/Test/MutantDataTable|Mutant activity relative to CapD_CP in table form]]
 +
<br style="clear: both" />
 +
 
 +
<span id = capH>
 +
 
 +
==Characterization of best hits==
 +
To further characterize the most promising mutant, F24H, we ran a Michaelis-Menten profile in order to obtain it's kinetic parameters and compare them to CapD.  In this case we ran our standard enzyme assay (5nM enzyme), but we varied the substrate from 1microM down to 0microM.  The resulting substrate vs. velocity curves for CapD_CP and the F24H variant are shown below.  Both enzymes showed canonical substrate inhibition trends, so the curve we fit them to was:  ''k''obs = (''k''cat * S0)/(Km+S0*(1+S0/Ki)).
 +
 
 +
[[Image:Washington_CP_F24H_MMCurves.png|thumb|700px|center|'''Figure 5.  Substrate vs. Velocity curves to determine the catalytic paramters if CapD_CP (left) and CapD_CP-F24H (right).''']]
 +
 
 +
[[Image:Washington_CP_F24H_Constants.png|thumb|400px|center|'''Table 2.  Kinetic parameters of CapD_CP vs. CapD_CP-F24H show that the mutant achieved the desired goal of having a minimal effect on hydrolysis activity (''k''cat), but has significantly reduced transpeptidation activity.''']]
 +
 
 +
<br style="clear: both" />
 +
</span>
 +
 
 +
==Summary==
 +
 
 +
These results show that our mutant has converted CapD_CP from an enzyme that strongly prefers transpeptidation into one that performs transpeptidation equally as well as it does hydrolysis.  The effects of this on anthrax need to be more thoroughly characterized, but that is beyond the scope of our project.  In addition, we hope to continue working on this project after the completion of iGEM in order to find additional variants that will start increasing hydrolysis activity.
 +
 
 +
 
 +
<br style="clear: both" />
-
[[Image:Washington_Mutant_design.jpg|thumb|400px|right|]]
 
<!---------------------------------------PAGE CONTENT GOES ABOVE THIS---------------------------------------->
<!---------------------------------------PAGE CONTENT GOES ABOVE THIS---------------------------------------->
<div style="text-align:center">
<div style="text-align:center">
-
'''&larr; [[Team:Washington/Project/Baker/Build|Building the Gram(+) Therapeutic]]'''
+
'''&larr; [[Team:Washington/Gram Positive/Build|Building the Gram(+) Therapeutic]]'''
&nbsp;
&nbsp;
&nbsp;
&nbsp;
&nbsp;
&nbsp;
-
'''[[Team:Washington/Project/Mougous|Overview of Gram(-) Therapeutic]] &rarr;'''
+
'''[[Team:Washington/Tools Created|Overview of Tools We Created]] &rarr;'''
-
</div>
+
{{Template:Team:Washington/Templates/Footer}}
{{Template:Team:Washington/Templates/Footer}}

Latest revision as of 20:59, 27 October 2010


Construction of CapD_CP

CapD_CP runs on a gel as one clean band

Figure 1. CapD_CP as expected. Right: CapD has ambiguous bands, making quantifying difficult and assaying protein activity less accurate


Depicted in Figure 1 is a gel comparing purified CapD and CapD_CP. This demonstrates one of the major advantages of CapD_CP,in addition to the fact that it is easy to express, it comes out in one clean band and is easy to quantify.


CapD shows three bands, while the lower two bands are the expected pieces that occur after the enzyme undergoes self cleavage, the upper band is of unclear origin. Its mass corresponds to what would either be the unprocessed, inactive and monomeric form of the enzymes or the dimeric form that didn't denature. This ambiguity makes the amount of active CapD enzyme difficult to quantify.



CapD_CP is expressed at EXACTLY the correct molecular weight

In Figure 2 (below) we show the mass spec conformation of the molecular weight of CapD_CP. As expected, the N-terminal methionine is cleaved off by the native E. coli methionine aminopeptidase, resulting in a high level of pure active enzyme.

Figure 2. Expected weight of CapD_CP without Methionine=55285Da, with Methionine=55417Da. Our mass spec detected a peak at 55274.8Da (no Methionine) well within the 0.02% error limit for our mass spec


The circular permutation didn't result in a loss of activity

In the table 1 (below), we show the kinetic paramters for CapD and CapD_CP as determined using our enzyme assay. Due to the heterogenous mix of active (processed) and inactive (unprocessed) protein, the kcat is difficult to quantify. The data we obtained suggests that the kinetic parameters of CapD and CapD_CP are within error of each other. Therefore the circular permutation of CapD did not have a negative effect on catalytic activity, suggesting that auto-processing is not required for catalysis but simply a regulatory feature.

Table 1. Kinetic properties determined for a Michaelis-Menten profile of CapD and CapD_CP, as described in our protocols section.



Catalytic Residue knock-outs show that CapD_CP is catalyzing the reaction as expected

Before we could predict which mutations increase hydrolysis capability, we needed to validate that the circularly permuted version of CapD had measurable activity for further assessments. We also hypothesized a threonine residue in the catalytic site of CapD_CP plays an important role in the catalysis reaction and mutating it will eliminate all enzymatic activity. Thus using FoldIt we created two mutants, T2V and T2A, to act as negative controls and ran an enzyme assay to confirm our hypothesis. The result shown in figure 3 (below) of this assay confirmed our hypothesis that CapD_CP has enzymatic activity compared to the two catalytic knockouts. The relatively flat activity curves of the knockout mutants confirmed the hypothesis of the threonine's role in the catalytic site.

Figure 3: Confirming the activity of CapD_CP by comparing it to two CapD_CP knockouts, T2A and T2V.


Removing CapD_CP Transpeptidase Activity

Screening Mutant Libraries

By standardizing the activity slope of each design relative to CapD_CP, a scatterplot easily portrays the qualities of each mutant. Several designs show negative catalytic curves similar to the catalytic knockouts. Some immediately show a negative activity curve meaning decrease in transpeptidation, hydrolysis, or both. F24H is our most promising mutant hydrolase design.

Figure 4. Plot of the Transpeptidation vs. Hydrolysis, relative to the starting protein CapD_CP. The goal is to remove as much transpeptidation activity as possible while maintaining or increasing hydrolysis activity. This will allow the protein to break down (via the hydrolysis reaction) the protective coat without building it back up (via the transpeptidation reaction)

Mutant activity relative to CapD_CP in table form

Characterization of best hits

To further characterize the most promising mutant, F24H, we ran a Michaelis-Menten profile in order to obtain it's kinetic parameters and compare them to CapD. In this case we ran our standard enzyme assay (5nM enzyme), but we varied the substrate from 1microM down to 0microM. The resulting substrate vs. velocity curves for CapD_CP and the F24H variant are shown below. Both enzymes showed canonical substrate inhibition trends, so the curve we fit them to was: kobs = (kcat * S0)/(Km+S0*(1+S0/Ki)).

Figure 5. Substrate vs. Velocity curves to determine the catalytic paramters if CapD_CP (left) and CapD_CP-F24H (right).
Table 2. Kinetic parameters of CapD_CP vs. CapD_CP-F24H show that the mutant achieved the desired goal of having a minimal effect on hydrolysis activity (kcat), but has significantly reduced transpeptidation activity.


Summary

These results show that our mutant has converted CapD_CP from an enzyme that strongly prefers transpeptidation into one that performs transpeptidation equally as well as it does hydrolysis. The effects of this on anthrax need to be more thoroughly characterized, but that is beyond the scope of our project. In addition, we hope to continue working on this project after the completion of iGEM in order to find additional variants that will start increasing hydrolysis activity.




Building the Gram(+) Therapeutic       Overview of Tools We Created